Verastem (VSTM) Change in Account Payables (2011 - 2026)
Verastem (VSTM) posted quarterly Change in Account Payables of -$2.8 million for Q1 2026, down 189.69% year-over-year from $3.2 million in Q1 2025, and down 172.9% quarter-over-quarter from $3.9 million in Q4 2025.
Powered by 
Analysis
Verastem (VSTM) Change in Account Payables (2011 - 2026) Analysis & Trends
Verastem's Change in Account Payables history runs 16 years deep, the most recent figure standing at -$2.8 million for Q1 2026.
- In Q1 2026, Change in Account Payables fell 189.69% year-over-year to -$2.8 million; the TTM figure through Mar 2026 stood at $2.4 million (up 1061.2% YoY), while the FY2025 annual figure was $8.4 million, up 366.69% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$2.8 million, down from $3.9 million in the prior quarter.
- The five-year high for Change in Account Payables was $3.9 million in Q4 2025, with the low at -$2.8 million in Q1 2026.
- The 5-year median for Change in Account Payables is $92000.0 (2022), against an average of $429411.8.
- Peak annual rise in Change in Account Payables reached 13150.0% in 2024, while the deepest fall reached 450.55% in 2024.
- Verastem's Change in Account Payables stood at -$458000.0 in 2022, then jumped by 551.09% to $2.1 million in 2023, then plunged by 119.94% to -$412000.0 in 2024, then soared by 1047.57% to $3.9 million in 2025, then plunged by 172.9% to -$2.8 million in 2026.
- Business Quant data shows VSTM's Change in Account Payables at -$2.8 million in Q1 2026, $3.9 million in Q4 2025, and $497000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Verastem | 815.85 Mn | 679.49 Mn | 36.32 Mn | 8.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.40 Mn |
| Mar 31, 2026 | -2.85 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Sep 30, 2025 | 497,000.00 |
| Jun 30, 2025 | 848,000.00 |
| Mar 31, 2025 | 3.17 Mn |
| Dec 31, 2024 | -412,000.00 |
| Sep 30, 2024 | -2.24 Mn |
| Jun 30, 2024 | -771,000.00 |
| Mar 31, 2024 | 265,000.00 |
| Dec 31, 2023 | 2.07 Mn |
| Sep 30, 2023 | 639,000.00 |
| Jun 30, 2023 | -424,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Dec 31, 2022 | -458,000.00 |
| Sep 30, 2022 | 3.65 Mn |
| Jun 30, 2022 | -688,000.00 |
| Mar 31, 2022 | 92,000.00 |
| Dec 31, 2021 | 1.66 Mn |
| Sep 30, 2021 | -754,000.00 |